H.R. 6389 · 111th Congress
Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
TownsSponsorNo cosponsors.
Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010 or the PROSTATE Act - Requires the Secretary of Veterans Affairs (VA) to establish the Interagency Prostate Cancer Coordination and Education Task Force, which shall: (1) develop a summary of advances in federal prostate cancer research and compile a list of…
What it does: CRS summary · Introduced in House · Sep 29, 2010
Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010 or the PROSTATE Act - Requires the Secretary of Veterans Affairs (VA) to establish the Interagency Prostate Cancer Coordination and Education Task Force, which shall: (1) develop a summary of advances in federal prostate cancer research and compile a list of best practices for treatment of prostate cancer that warrant broader adoption in health care programs; (2) consider establishing guidance to enable physicians to allow screening of men over age 74; (3) coordinate information on federal research and health care program activities relating to prostate cancer; (4) develop a comprehensive interagency strategy on, and advise agencies in, the solicitation of proposals for collaborative, multidisciplinary research and health care programs relating to prostate cancer; (5) develop a coordinated message related to screening and treatment for prostate cancer to be reflected in educational and beneficiary materials for federal health programs; and (6) submit recommendations regarding federal research and health care programs.
Directs the Secretary to establish and carry out a program to coordinate and intensify prostate cancer research, including by establishing clinical registries for prostate cancer and awarding research grants.
Establishes in the Office of the Chief Scientist of the Food and Drug Administration (FDA) a Prostate Cancer Scientific Advisory Board to be responsible for accelerating real-time sharing of the latest research data and accelerating movement of new medicines to patients.
Directs the Secretary to: (1) establish four-year telehealth pilot projects for the purpose of analyzing the clinical outcomes and cost effectiveness associated with telehealth services in a variety of geographic areas that contain high proportions of medically underserved populations and those in rural areas; and (2) develop a national education campaign for prostate cancer.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Prostate Research, Outreach, Screening, Testing, Access, and Treatment Effectiveness Act of 2010
Also known as: PROSTATE Act
Latest action (Oct 20, 2010): Referred to the Subcommittee on Military Personnel.
Policy area: Health · Origin: House · Introduced: Sep 29, 2010
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.